The startup offers a data analytics platform that provides life science professionals with access to financial, clinical, scientific, and regulatory information. Its features, including drug identification and data extraction, enable clients to efficiently track drug development and monitor competitive landscapes.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Life science professionals face the challenge of efficiently accessing and analyzing the vast amounts of financial, clinical, scientific, and regulatory information required to make informed decisions. Sifting through disparate sources to track drug development, monitor competitive landscapes, and identify investment opportunities is time-consuming and can lead to missed insights.
Solution
Catailyst is a data analytics platform that consolidates life science information, providing users with AI-driven insights and actionable intelligence. The platform offers a web-based portal with customizable alerts, data visualizations, and weekly reports, enabling users to track company activities, clinical trial progress, regulatory events, and market trends. By applying machine learning and natural language processing to analyze data from press releases, SEC filings, clinical trial registries, and other sources, Catailyst delivers structured and searchable data, facilitating strategic planning, market analysis, and investment decisions.
Target Audience
Catailyst serves professionals in pharmaceutical and biotech companies, including business development, competitive intelligence, strategy, clinical/medical affairs, and commercial teams, as well as investors (venture capitalists and hedge fund managers), management and strategy consultants, investment bankers, research analysts, and life science service providers.
Features
- Real-time alerts for tracking company activities, clinical trial registrations, and regulatory events
- Integrated data from global clinical trial registries (US, EU, Japan, Australia, New Zealand)
- Interactive Tableau modules for visualizing and benchmarking clinical trials
- AI-powered analysis of therapeutic modalities, development stages, and mechanisms of action to predict investment attractiveness
- Co-investment knowledge graphs to leverage insights from experienced investors
- Customizable search filters based on date range, category, and content type
- Weekly reports summarizing key industry trends and developments